AG003OP1

62571-86-2 | 1-[(2S)-3-Mercapto-2-methyl-1-oxopropyl]-L-proline

AG003OP1

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	62571-86-2
Catalog Number	AG003OP1(AGN-PC-0ODS7R)
Chemical Name	1-[(2S)-3-Mercapto-2-methyl-1-oxopropyl]-L-proline
EC Number	263-607-1
IUPAC Name	(2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid
InChI	InChI=1S/C9H15NO3S/c1-6(5-14)8(11)10-4-2-3-7(10)9(12)13/h6-7,14H,2-5H2,1H3,(H,12,13)/t6-,7+/m1/s1
InChI Key	FAKRSMQSSFJEIM-RQJHMYQMSA-N
MDL Number	MFCD00168073
Molecular Formula	C9H15NO3S
Molecular Weight	217.2853
NSC Number	757419
SMILES	C(=O)([C@@H](CS)C)N1[C@H](C(=O)O)CCC1
UNII	9G64RSX1XD
Synonyms	(S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline, Capoten, Captopril, Lopirin, SQ 14,225, SQ 14,534, SQ 14225, SQ 14534, SQ-14,225, SQ-14,534, SQ-14225, SQ-14534, SQ14,225, SQ14,534, SQ14225, SQ14534, captopril, 62571-86-2, L-Captopril, Capoten, Captopryl, Lopirin, Cesplon, Captolane, Tensoprel, Acepress, Captoril, Dilabar, Garranil, Hypertil, Tenosbon, Alopresin, Captoprilum, Acepril, Lopril, Acediur, Aceplus, Isopresol, Tensobon, Apopril, Asisten, Captoprilum [INN-Latin], SQ-14225, D-2-Methyl-3-mercaptopropanoyl-L-proline, (2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid, Hipertil, Lopirin [Switzerland], SQ 14225, D-3-Mercapto-2-methylpropanoyl-L-proline, SQ 14,225, SA 333, D-3-Mercapto-2-methylpropionylproline, (2S)-1-(3-Mercapto-2-methylpropionyl)-L-proline, 1-((2S)-3-Mercapto-2-methylpropionyl)-L-proline, UNII-9G64RSX1XD, 3-Mercapto-2-methylpropionyl-proline, 1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline, CHEBI:3380, 1-[(2S)-2-methyl-3-sulfanylpropanoyl]-L-proline, HSDB 6527, EINECS 263-607-1, 9G64RSX1XD, CHEMBL1560, 1-[(2S)-3-Mercapto-2-methyl-1-oxopropyl]-L-proline, C9H15NO3S, MLS000069484, 1-(D-3-Mercapto-2-methyl-1-oxopropyl)-L-proline (S,S), L-Proline, 1-[(2S)-3-mercapto-2-methyl-1-oxopropyl]-, L-Proline, 1-(3-mercapto-2-methyl-1-oxopropyl)-, (S)-, FAKRSMQSSFJEIM-RQJHMYQMSA-N, (-)-Captopril, [2S]-1-[3-Mercapto-2-methylpropionyl]-L-proline, Captopril, 98%, MFCD00168073, NCGC00023654-04, SMR000059061, 1-Pyrrolidinecarboxylic acid, 1-(D-3-mercapto-2-methyl-1-propionyl)-, L-(S,S)-, DSSTox_CID_17197, DSSTox_RID_79306, (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline, DSSTox_GSID_37197, L-Proline, 1-((2S)-3-mercapto-2-methyl-1-oxopropyl)-, Novocaptopril, Captril, Farcopril, Hypopress, Tensiomin, Zapto, Captopril (Capoten), Capozide (Salt/Mix), SQ-14534, X8Z, Apopril (TN), Capoten (TN), Garranil (discontinued), Captopril [USAN:INN:BAN:JAN], 1-[(2s)-3-mercapto-2-methylpropionyl]-l-proline, SR-01000075603, component of Captea (Salt/Mix), component of Acezide (Salt/Mix), component of Ecazide (Salt/Mix), captopril-capoten, (2S)-1-((2S)-2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid, (S)-1-((S)-3-mercapto-2-methylpropanoyl)pyrrolidine-2-carboxylic acid, Captopril,(S), Prestwick_103, Captopril [USAN:USP:INN:BAN:JAN], SCHEMBL4, Spectrum_000688, SQ-14,225, SQ-14,534, Opera_ID_1041, Prestwick3_000019, Spectrum2_001211, Spectrum3_001388, Spectrum4_000811, Spectrum5_001587, Lopac-C-4042, 1-((2S)-2-Methyl-3-sulfanylpropanoyl)-L-proline #, Epitope ID:114065, UPCMLD-DP003, C 4042, AC1L2B4L, AC1Q29GZ, Lopac0_000302, N-[(S)-3-Mercapto-2-methylpropionyl]-L-proline, BSPBio_000057, BSPBio_002976, KBioGR_001321, KBioSS_001168, MLS001076488, DivK1c_000208, SPECTRUM1500682, SPBio_001022, Captopril (JP17/USP/INN), (S)-1-(3-Mercapto-2-methyl-1-oxo-propyl)-L-proline, AC1Q5R48, BPBio1_000063, GTPL5158, DTXSID1037197, UPCMLD-DP003:001, BDBM21642, HMS500K10, KBio1_000208, KBio2_001168, KBio2_003736, KBio2_006304, KBio3_002196, KS-00000XHT, ZINC57001, 1j37, NINDS_000208, HMS1921C12, HMS2089P19, HMS2092I12, HMS2095C19, HMS2233I04, HMS3259G10, HMS3260N06, HMS3712C19, Pharmakon1600-01500682, HY-B0368, Tox21_110890, Tox21_500302, BBL033600, CCG-39104, EI-213, KM0635, NSC757419, s2051, SBB017523, STK802012, AKOS005622581, Captopril, >=98% (HPLC), powder, Tox21_110890_1, AB04252, BCP9000485, CS-2425, DB01197, KS-5025, LP00302, MCULE-1716939647, NC00554, NSC-757419, SQ14534, IDI1_000208, SMP1_000056, NCGC00015235-01, NCGC00015235-02, NCGC00023654-03, NCGC00023654-05, NCGC00023654-06, NCGC00023654-07, NCGC00023654-08, NCGC00023654-09, NCGC00023654-10, NCGC00023654-11, NCGC00023654-13, NCGC00260987-01, AC-12047, BC203925, CPD000059061, SAM002564201, ST079562, SBI-0050290.P004, AB0007072, AB2000455, Captopril, meets USP testing specifications, LS-137465, EU-0100302, FT-0082749, ((S)-3-mercapto-2-methylpropanoyl)-L-proline, BIM-0050290.0001, C06867, D00251, J10167, 54254-EP2269989A1, 54254-EP2270011A1, 54254-EP2272841A1, 54254-EP2277879A1, 54254-EP2287165A2, 54254-EP2287166A2, 54254-EP2292620A2, 54254-EP2295406A1, 54254-EP2298742A1, 54254-EP2298772A1, 54254-EP2298776A1, 54254-EP2298779A1, 54254-EP2301923A1, 54254-EP2301931A1, 54254-EP2301936A1, 54254-EP2305219A1, 54254-EP2305648A1, 54254-EP2308562A2, 54254-EP2308839A1, AB00052156-16, AB00052156_17, AB00052156_18, 571C862, SR-01000000039, 1-[(2S)-3-Mercapto-2-methylpropionyl]- L-proline, SR-01000000039-2, SR-01000075603-1, SR-01000075603-3, 1-[(S)-3-mercapto-2-methyl-1-oxopropyl]-L-proline, BRD-K54529596-001-04-0, BRD-K54529596-001-15-6, Captopril, British Pharmacopoeia (BP) Reference Standard, Z2786051697, Captopril, European Pharmacopoeia (EP) Reference Standard, Captopril, United States Pharmacopeia (USP) Reference Standard, Captopril, Pharmaceutical Secondary Standard; Certified Reference Material, L-?Proline, 1-?[(2S)?-?3-?mercapto-?2-?methyl-?1-?oxopropyl]?-, Captopril for system suitability, European Pharmacopoeia (EP) Reference Standard, Capozide, Mixture Name, S-Captopril, D0I0EG, CAPOZIDE 25/15, CAPOZIDE 25/25, CAPOZIDE 50/15, CAPOZIDE 50/25, Captopril (JP15/USP/INN), ACE-01, Captopril [USAN:BAN:INN:JAN], C9-H15-N-O3-S, CID44093, ACN-048756, CS-O-00875, CS-O-01051, SQ14225, CAPTOPRIL AND HYDROCHLOROTHIAZIDE, CAS-62571-86-2, A11738, 1-(D-3-Mercapto-2-methyl-1-oxopropyl)-L-proline, L-prolina, 1-[(2S)-3-mercapto-2-metil-1-] oxopropil-, Captopril, 98%, an angiotensin-converting enzyme (ACE) inhibitor - 5G 5g, CP, MCO,

Complexity	244
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	2
Defined Bond Stereocenter Count	0
Exact Mass	217.077g/mol
Formal Charge	0
Heavy Atom Count	14
Hydrogen Bond Acceptor Count	4
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	217.283g/mol
Monoisotopic Mass	217.077g/mol
Rotatable Bond Count	3
Topological Polar Surface Area	58.6A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	0.3

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H303
Packing Group
Precautionary statements	P312
UN Code

Certificate of Analysis

Lot Number